| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 9e-05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |